MeSH tree: D02.455.426.559.389.150
A new research paper was published in Aging titled, "The coupling between healthspan and lifespan in Caenorhabditis depends on complex interactions between compound intervention and genetic background."
Apr 23, 2024
0
35
Online stores sprang up during the COVID-19 pandemic's telehealth boom touting testosterone as a cure-all for men's age-related illnesses—despite FDA rules issued years ago restricting such "low testosterone" advertising.
Mar 28, 2024
0
39
Rice University synthetic biologists have found a way to piggyback on the glucose monitoring technology used in automated insulin dosing systems and make it universally applicable for the monitoring and dosing of virtually ...
Mar 15, 2024
0
43
A new research paper was published on the cover of Aging titled, "Effects of resveratrol on in vitro circadian clock gene expression in young and older human adipose-derived progenitor cells."
Jan 16, 2024
0
51
While some engineered stone producers are promoting reduced-silica or silica-free products due to health concerns, researchers have found other substances in the material are damaging workers' lungs.
Dec 8, 2023
0
81
Nanoplastics interact with a particular protein that is naturally found in the brain, creating changes linked to Parkinson's disease and some types of dementia.
Nov 17, 2023
0
144
Cancer treatment is riddled with pros and cons, trade-offs. During October, breast cancer awareness month, the spotlight shines on endocrine therapy or "hormonal therapy." The drug, Tamoxifen, and others like it that shut ...
Oct 18, 2023
0
45
Research by experts from Ningbo Eye Hospital and Hwa Mei Hospital at the University of Chinese Academy of Sciences provides insight into a critical issue facing surgical patients: post-operative cognitive dysfunction (POCD).
Sep 14, 2023
0
53
For roughly 80% of breast cancer survivors, treatment doesn't end with surgery, radiation and chemotherapy. Instead, for the next five to 10 years, doctors recommend that they take medication to block sex hormones, which ...
Aug 28, 2023
0
54
The U.S. government could save taxpayers between $228 million and $2.15 billion a year if insurers who operate its Medicare Part D plans purchased seven generic oncology drugs at the same prices obtained by the Mark Cuban ...
Jun 8, 2023
0
51
